ANNA CHERNYAK: Open Payments
NPI 1558437665 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 47 payments from 14 companies in 2025. Trend: 2023 $1,019 · 2024 $1,007 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $392 |
| ABBVIE INC. | 17 | $212 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Lilly USA, LLC | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $75 |
| Novo Nordisk Inc | 3 | $55 |
| Exact Sciences Corporation | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| PFIZER INC. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, JARDIANCE, AUSTEDO XR, MOUNJARO, The Cologuard Plus Collection Kit, Rybelsus.
Industry payments across NJ — which companies pay providers there.
